Cytori Therapeutics Inc (NASDAQ:CYTX)

Data as of Jan 28
 -0.0214 / -4.27%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose-derived stem and regenerative cells to treat cardiovascular disease and repair soft tissue defects. It automates the extraction and preparation of clinical grade adipose-derived stem and regenerative cells using device, Celution system. The company sells its products to researchers at academic centers and hospitals to fulfill the demand for access to stem and regenerative cells at the point-of-care. It offers a range of products designed to optimize tissue harvest and graft delivery which include Cellbrush, a surgical instrument for precise delivery of micro droplets. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.

Contact Information

Cytori Therapeutics, Inc.
3020 Callan Road
San Diego California 92121
P:(858) 458-0900
Investor Relations:
(858) 875-5279



Mutual fund holders6.43%
Other institutional21.48%
Individual stakeholders15.59%

Top Executives

Marc H. HedrickPresident, Chief Executive Officer & Director
Douglas M. ArmSenior Vice President-Operations
Tiago GirãoChief Financial Officer & Vice President
Steven KestenChief Medical Officer & Executive Vice President
Seijiro Norio ShirahamaPresident-Asia Pacific

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.